Australian Pain Society Blog, 30 May 2022
The following is a summary from the 42nd Annual Scientific Meeting of the Australian Pain Society, which took place from April 10-13 in Hobart, Tasmania. This year, the Meeting featured a new item on the program—a debate. The inaugural debate focused on whether medicinal cannabis is the next opioid crisis. The evidence (or lack thereof) for medicinal cannabis use in the pain sector was discussed, with unique insights from political and consumer perspectives in addition those provided from clinicians and researchers. Read on to see how the debate played out. Read more.